Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Janssen Biotech presents DHODH inhibitors

May 4, 2021

Shanghai HaiHe Biopharma patents BRD4 inhibitors

May 4, 2021

First direct KRAS G12V(ON) inhibitors developed at Revolution Medicines

May 4, 2021

FDA approves IND for KRAS G12C inhibitor JAB-21822

May 4, 2021

Repare initiates phase I trial of oral PKMYT1 inhibitor RP-6306

May 3, 2021

Monte Rosa Therapeutics discloses new protein cereblon modulators

May 3, 2021

Patient dosing begins in phase Ib/II study of CFI-400945 in leukemia

May 3, 2021

A different path to specificity for Ras inhibitors

May 3, 2021

Phase IIb/III study of masitinib in metastatic CRPC meets primary endpoint

April 30, 2021

PRT-1419 shows potent antitumor activity in preclinical models

April 30, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
LIT-002 is strong candidate for autism and neuropathic pain
BioWorld Science
Researchers from the University of Strasbourg and the Centre National de la Recherche Scientifique (CNRS) have presented data on LIT-002, a nonpeptide oxytocin...